8-K: Cocrystal Pharma Files Corrected Auditor Consent in Form 8-K
Current Report
Cocrystal Pharma files a corrected version of its auditor's consent to include a reference to the company's effective registration statement on Form S-3.
Summary
- Cocrystal Pharma, Inc. filed a Form 8-K to submit a corrected version of the auditor's consent.
- The correction adds a reference to the company's effective registration statement on Form S-3 (No. 333-271883), which was previously omitted.
- The corrected consent is filed as Exhibit 23.1 of the Form 8-K and is incorporated by reference into the Registration Statement.
- Weinberg & Company P.A. provided the consent, referencing their report dated March 31, 2025, on the consolidated financial statements of Cocrystal Pharma, Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, correcting a previously submitted document. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
This filing is a routine regulatory update and doesn't significantly alter the understanding of Cocrystal Pharma's position within the pharmaceutical industry.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | Fiscal year end for the Annual Report on Form 10-K |
| 2025-03-31 | Date of auditor's report on consolidated financial statements |
| 2025-03-31 | Date of filing of the Annual Report on Form 10-K |
| 2025-03-31 | Date of the earliest event reported |
| 2025-04-01 | Date of Form 8-K filing and auditor's consent |
Keywords
Form 8-K, auditor consent, Cocrystal Pharma, registration statement, Weinberg & Company, financial statements
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.